Matteo Accinno

High proportion of inflammatory CD62L^low eosinophils in blood and nasal polyps of severe asthma patients

Andrea Matucci, Francesca Nencini, Giandomenico Maggiore et al. · Clinical & Experimental Allergy · 2022 · 43 citations · Full text

Medicine, Immunology, Otolaryngology +17

Blood <scp>CD62L^low</scp> inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab

Alessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli et al. · Allergy · 2023 · 37 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies

Maxime Teisseyre, Marco Allinovi, Vincent Audard et al. · Kidney International Reports · 2024 · 32 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +15

EGPA Phenotyping: Not Only ANCA, but Also Eosinophils

Andrea Matucci, Emanuele Vivarelli, Margherita Perlato et al. · Biomedicines · 2023 · 21 citations · Full text

Life Sciences, Immunology, Pathology +16

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy

Marco Allinovi, Maxime Teisseyre, Matteo Accinno et al. · Kidney International Reports · 2025 · 17 citations · Full text

Medicine, Immunology, Nephrology +17